ADMA Biologics
ADMA
ADMA
163 hedge funds and large institutions have $547M invested in ADMA Biologics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 160 → 163 (+3)
8% less capital invested
Capital invested by funds: $592M → $547M (-$44.7M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
163
Holding in Top 10
5
Calls
$2.01M
Puts
$930K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$6.56M | |
| 3 | +$4.9M | |
| 4 |
Two Sigma Advisers
New York
|
+$4.79M |
| 5 |
BlackRock
New York
|
+$4.27M |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$5.1M | |
| 3 | -$3.5M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$3.46M |
| 5 |
CP
Caligan Partners
New York
|
-$3.35M |